Paper

Radiomodifying action, Pharmacokinetic and Biodistribution of Ethyl 3, 4, 5-trihydroxybenzoate-Implication in development of radiomitigator

Published Dec 1, 2019 · P. Pandey, P. Pandey, B. Ahmed

Scientific Reports

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCTAnimal StudyRigorous Journal

Study Snapshot

Ethyl 3, 4, 5-trihydroxybenzoate (GAE) shows potential as a radiomodifying agent, inhibiting NF-kB expression and maintaining liver and kidney function after irradiation.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Radiomodifying action, Pharmacokinetic and Biodistribution of Ethyl 3, 4, 5-trihydroxybenzoate-Implication in development of radiomitigator

References

Citations